Global Medical Affairs Director - Diagnostics, Lung

AstraZeneca•Gaithersburg, MD

21h

About The Position

Accountabilities: - Global Diagnostic Strategy: Lead a unified diagnostics strategy for the lung portfolio, providing timely, high-quality input into global medical and lifecycle plans to deliver in-market companion diagnostics and testing solutions that enable optimal treatment selection and patient access. - Strategic Partnerships: Build long-term, trust-based relationships with advocacy groups, scientific organizations, thought leaders, and HTA/payer bodies to shape best-in-class diagnostic capabilities aligned to portfolio medical needs. - Diagnostics Medical Affairs Leadership: Direct all diagnostics-related Medical Affairs activities in collaboration with Tumor/Asset medical leaders, spanning scientific advisory boards, publications planning, evidence generation, diagnostic plan integration, and externally sponsored research and collaborations. - Confidence Generation: Lead symposia, summits, and internal/external education to elevate diagnostic evidence and drive adoption of testing strategies among clinicians and health systems. - Integration Across Assets: Embed diagnostic strategies in Tumor/Asset medical plans and provide diagnostics insights that inform broader strategy development and execution. - Enterprise Contribution: Influence enterprise-level strategic planning to strengthen AstraZeneca’s leadership in medical diagnostics and shape future standards of care. - Compliance Stewardship: Uphold AstraZeneca standards, SOPs, and external regulations across all medical and business activities. Why AstraZeneca: Here, science and strategy converge to change clinical practice. You will collaborate with diverse experts who challenge assumptions, translate evidence into real-world impact, and move quickly from insight to action. We bring data, real-world evidence, and clinical expertise together to influence every point in the patient journey, while fostering a culture where people speak up, listen actively, and learn from bold ideas. With a deep pipeline and strong external partnerships, you will shape diagnostics that improve outcomes for people living with cancer, supported by leaders who value kindness alongside ambition and make space for you to grow, take smart risks, and deliver meaningful progress. Seize the opportunity to lead the future of lung cancer diagnostics and turn evidence into better outcomes for patients—step forward and make your impact today!

Requirements

Lead global diagnostic strategy, ensuring timely, high-quality input into global medical and lifecycle plans to deliver in-market companion diagnostics and testing solutions that enable optimal treatment selection and patient access to the right therapies.
Develop long-term, trust-based relationships with key external oncology stakeholders—advocacy groups, scientific organizations, thought leaders, and HTA/payer bodies—to shape best-in-class diagnostic capabilities aligned to portfolio medical needs.
Provide leadership across all diagnostics-related Medical Affairs activities in collaboration with Tumor/Asset medical leaders, including scientific advisory boards, publications planning, evidence generation, diagnostic plan integration, and externally sponsored research and collaborations.
Lead diagnostic confidence-generation initiatives—symposia, summits, and internal/external education—to accelerate understanding and adoption of testing strategies.
Embed diagnostic strategies within Tumor/Asset medical plans and contribute diagnostics insights that inform the development and execution of broader Tumor/Asset strategies.
Contribute to enterprise-level strategic planning to strengthen AstraZeneca’s leadership in medical diagnostics.
Ensure all medical and business activities meet AstraZeneca standards, SOPs, and external regulations.

Nice To Haves

Demonstrated impact advancing companion diagnostics in oncology, ideally including lung cancer biomarkers and testing pathways.
Track record designing and executing medical evidence strategies that inform HTA/payer perspectives and clinical practice.
Experience leading clinical and scientific advisory boards and integrating diagnostic publications within asset publication plans.
Success guiding externally sponsored research and multi-center collaborations to address diagnostic adoption and access barriers.
Ability to translate complex diagnostic science into clear, actionable education for diverse audiences across regions.
Comfort operating globally and cross-functionally, engaging R&D, Commercial, Market Access, and external partners to deliver results.

Responsibilities

Lead a unified diagnostics strategy for the lung portfolio.
Build long-term, trust-based relationships with advocacy groups, scientific organizations, thought leaders, and HTA/payer bodies.
Direct all diagnostics-related Medical Affairs activities in collaboration with Tumor/Asset medical leaders.
Lead symposia, summits, and internal/external education to elevate diagnostic evidence and drive adoption of testing strategies among clinicians and health systems.
Embed diagnostic strategies in Tumor/Asset medical plans and provide diagnostics insights that inform broader strategy development and execution.
Influence enterprise-level strategic planning to strengthen AstraZeneca’s leadership in medical diagnostics and shape future standards of care.
Uphold AstraZeneca standards, SOPs, and external regulations across all medical and business activities.
Lead global diagnostic strategy, ensuring timely, high-quality input into global medical and lifecycle plans to deliver in-market companion diagnostics and testing solutions that enable optimal treatment selection and patient access to the right therapies.
Develop long-term, trust-based relationships with key external oncology stakeholders—advocacy groups, scientific organizations, thought leaders, and HTA/payer bodies—to shape best-in-class diagnostic capabilities aligned to portfolio medical needs.
Provide leadership across all diagnostics-related Medical Affairs activities in collaboration with Tumor/Asset medical leaders, including scientific advisory boards, publications planning, evidence generation, diagnostic plan integration, and externally sponsored research and collaborations.
Lead diagnostic confidence-generation initiatives—symposia, summits, and internal/external education—to accelerate understanding and adoption of testing strategies.
Embed diagnostic strategies within Tumor/Asset medical plans and contribute diagnostics insights that inform the development and execution of broader Tumor/Asset strategies.
Contribute to enterprise-level strategic planning to strengthen AstraZeneca’s leadership in medical diagnostics.
Ensure all medical and business activities meet AstraZeneca standards, SOPs, and external regulations.

Benefits

Benefits offered included a qualified retirement program [401(k) plan]; paid vacation and holidays; paid leaves; and, health benefits including medical, prescription drug, dental, and vision coverage in accordance with the terms and conditions of the applicable plans.
Additional details of participation in these benefit plans will be provided if an employee receives an offer of employment.

Stand Out From the Crowd

Upload your resume and get instant feedback on how well it matches this job.

Upload and Match Resume